Profile of liver cholestatic biomarkers following prolonged ketamine administration in patients with COVID-19
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2253
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Profile of liver cholestatic biomarkers following prolonged ketamine administration in patients with COVID-19 ; volume:23 ; number:1 ; day:7 ; month:2 ; year:2023 ; pages:1-8 ; date:12.2023
BMC anesthesiology ; 23, Heft 1 (7.2.2023), 1-8, 12.2023
- Creator
-
Henrie, Julie
Gerard, Ludovic
Declerfayt, Caroline
Lejeune, Adrienne
Baldin, Pamela
Robert, Arnaud
Laterre, Pierre-François
Hantson, Philippe
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12871-023-02006-2
- URN
-
urn:nbn:de:101:1-2023041121024907280223
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Henrie, Julie
- Gerard, Ludovic
- Declerfayt, Caroline
- Lejeune, Adrienne
- Baldin, Pamela
- Robert, Arnaud
- Laterre, Pierre-François
- Hantson, Philippe
- SpringerLink (Online service)
Other Objects (12)
“Dosis sola facit venenum”—Evidence for causality in the association between ketamine and cholestatic liver injury
Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome
Bile acid-mediated signaling in cholestatic liver diseases
Mitochondrial Mutations in Cholestatic Liver Disease with Biliary Atresia
Cholestatic Liver Injury in a Patient with Tertiary Syphilis
Fibrotic Events in the Progression of Cholestatic Liver Disease
Delection of Caspase-8 in liver parenchymal cells protects against cholestatic liver injury
Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents
Rat precision-cut liver slices predict drug-induced cholestatic injury
The gut microbiota-bile acid axis in cholestatic liver disease
The role of liver regeneration-associated protein ALR, Augmenter of Liver Regeneration, in cholestatic liver diseases
Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis
“Dosis sola facit venenum”—Evidence for causality in the association between ketamine and cholestatic liver injury
Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome
Bile acid-mediated signaling in cholestatic liver diseases
Mitochondrial Mutations in Cholestatic Liver Disease with Biliary Atresia
Cholestatic Liver Injury in a Patient with Tertiary Syphilis
Fibrotic Events in the Progression of Cholestatic Liver Disease
Delection of Caspase-8 in liver parenchymal cells protects against cholestatic liver injury
Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents
Rat precision-cut liver slices predict drug-induced cholestatic injury
The gut microbiota-bile acid axis in cholestatic liver disease
The role of liver regeneration-associated protein ALR, Augmenter of Liver Regeneration, in cholestatic liver diseases
Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis
“Dosis sola facit venenum”—Evidence for causality in the association between ketamine and cholestatic liver injury
Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome
Bile acid-mediated signaling in cholestatic liver diseases
Mitochondrial Mutations in Cholestatic Liver Disease with Biliary Atresia
Cholestatic Liver Injury in a Patient with Tertiary Syphilis
Fibrotic Events in the Progression of Cholestatic Liver Disease
Delection of Caspase-8 in liver parenchymal cells protects against cholestatic liver injury
Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents
Rat precision-cut liver slices predict drug-induced cholestatic injury
The gut microbiota-bile acid axis in cholestatic liver disease
The role of liver regeneration-associated protein ALR, Augmenter of Liver Regeneration, in cholestatic liver diseases